Vesicle mediated transport, QA-SNARE
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0012505 | endomembrane system | 2 | 1 |
GO:0031201 | SNARE complex | 3 | 1 |
GO:0031982 | vesicle | 4 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0098796 | membrane protein complex | 2 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: A0A3Q8IF56
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 12 |
GO:0016192 | vesicle-mediated transport | 4 | 11 |
GO:0051179 | localization | 1 | 12 |
GO:0051234 | establishment of localization | 2 | 12 |
GO:0006886 | intracellular protein transport | 4 | 2 |
GO:0006906 | vesicle fusion | 6 | 1 |
GO:0006996 | organelle organization | 4 | 1 |
GO:0008104 | protein localization | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0015031 | protein transport | 4 | 2 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0016050 | vesicle organization | 5 | 1 |
GO:0022406 | membrane docking | 2 | 1 |
GO:0033036 | macromolecule localization | 2 | 2 |
GO:0045184 | establishment of protein localization | 3 | 2 |
GO:0046907 | intracellular transport | 3 | 2 |
GO:0048278 | vesicle docking | 4 | 1 |
GO:0048284 | organelle fusion | 5 | 1 |
GO:0051640 | organelle localization | 2 | 1 |
GO:0051641 | cellular localization | 2 | 2 |
GO:0051649 | establishment of localization in cell | 3 | 2 |
GO:0061024 | membrane organization | 4 | 1 |
GO:0061025 | membrane fusion | 5 | 1 |
GO:0070727 | cellular macromolecule localization | 3 | 2 |
GO:0071702 | organic substance transport | 4 | 2 |
GO:0071705 | nitrogen compound transport | 4 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:0090174 | organelle membrane fusion | 6 | 1 |
GO:0140056 | organelle localization by membrane tethering | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000149 | SNARE binding | 3 | 1 |
GO:0005484 | SNAP receptor activity | 3 | 2 |
GO:0005488 | binding | 1 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0030674 | protein-macromolecule adaptor activity | 2 | 2 |
GO:0060090 | molecular adaptor activity | 1 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 10 | 12 | PF00675 | 0.337 |
CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.355 |
CLV_NRD_NRD_1 | 221 | 223 | PF00675 | 0.455 |
CLV_NRD_NRD_1 | 31 | 33 | PF00675 | 0.318 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.371 |
CLV_NRD_NRD_1 | 65 | 67 | PF00675 | 0.376 |
CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.319 |
CLV_PCSK_KEX2_1 | 221 | 223 | PF00082 | 0.436 |
CLV_PCSK_KEX2_1 | 31 | 33 | PF00082 | 0.302 |
CLV_PCSK_KEX2_1 | 36 | 38 | PF00082 | 0.353 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.411 |
CLV_PCSK_PC1ET2_1 | 51 | 53 | PF00082 | 0.325 |
CLV_PCSK_PC7_1 | 32 | 38 | PF00082 | 0.417 |
CLV_PCSK_PC7_1 | 47 | 53 | PF00082 | 0.319 |
CLV_PCSK_SKI1_1 | 234 | 238 | PF00082 | 0.308 |
CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.383 |
CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.323 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.361 |
CLV_PCSK_SKI1_1 | 74 | 78 | PF00082 | 0.369 |
CLV_PCSK_SKI1_1 | 88 | 92 | PF00082 | 0.238 |
DOC_MAPK_gen_1 | 87 | 97 | PF00069 | 0.548 |
DOC_MAPK_MEF2A_6 | 232 | 240 | PF00069 | 0.423 |
DOC_PP1_RVXF_1 | 150 | 156 | PF00149 | 0.688 |
DOC_PP1_RVXF_1 | 232 | 238 | PF00149 | 0.488 |
DOC_USP7_MATH_1 | 228 | 232 | PF00917 | 0.620 |
DOC_USP7_MATH_1 | 245 | 249 | PF00917 | 0.211 |
DOC_USP7_UBL2_3 | 87 | 91 | PF12436 | 0.548 |
DOC_WW_Pin1_4 | 146 | 151 | PF00397 | 0.654 |
LIG_14-3-3_CanoR_1 | 36 | 41 | PF00244 | 0.598 |
LIG_APCC_ABBAyCdc20_2 | 109 | 115 | PF00400 | 0.554 |
LIG_FHA_1 | 169 | 175 | PF00498 | 0.571 |
LIG_FHA_2 | 101 | 107 | PF00498 | 0.562 |
LIG_FHA_2 | 43 | 49 | PF00498 | 0.489 |
LIG_LIR_Gen_1 | 158 | 165 | PF02991 | 0.686 |
LIG_LIR_Gen_1 | 183 | 192 | PF02991 | 0.492 |
LIG_LIR_Gen_1 | 71 | 78 | PF02991 | 0.488 |
LIG_LIR_Nem_3 | 158 | 163 | PF02991 | 0.687 |
LIG_LIR_Nem_3 | 183 | 188 | PF02991 | 0.487 |
LIG_LIR_Nem_3 | 71 | 75 | PF02991 | 0.475 |
LIG_SH2_STAP1 | 160 | 164 | PF00017 | 0.694 |
LIG_SUMO_SIM_anti_2 | 197 | 203 | PF11976 | 0.611 |
LIG_SUMO_SIM_par_1 | 242 | 248 | PF11976 | 0.324 |
LIG_TRAF2_1 | 39 | 42 | PF00917 | 0.608 |
LIG_WRC_WIRS_1 | 69 | 74 | PF05994 | 0.521 |
MOD_CDC14_SPxK_1 | 149 | 152 | PF00782 | 0.642 |
MOD_CDK_SPxK_1 | 146 | 152 | PF00069 | 0.651 |
MOD_CK2_1 | 204 | 210 | PF00069 | 0.639 |
MOD_CK2_1 | 35 | 41 | PF00069 | 0.658 |
MOD_CK2_1 | 42 | 48 | PF00069 | 0.610 |
MOD_Cter_Amidation | 85 | 88 | PF01082 | 0.380 |
MOD_GlcNHglycan | 115 | 118 | PF01048 | 0.428 |
MOD_GlcNHglycan | 207 | 210 | PF01048 | 0.469 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.618 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.691 |
MOD_GSK3_1 | 210 | 217 | PF00069 | 0.575 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.524 |
MOD_N-GLC_1 | 204 | 209 | PF02516 | 0.402 |
MOD_N-GLC_1 | 214 | 219 | PF02516 | 0.392 |
MOD_N-GLC_1 | 57 | 62 | PF02516 | 0.380 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.559 |
MOD_PIKK_1 | 214 | 220 | PF00454 | 0.613 |
MOD_PK_1 | 36 | 42 | PF00069 | 0.600 |
MOD_PKA_1 | 31 | 37 | PF00069 | 0.511 |
MOD_PKA_1 | 51 | 57 | PF00069 | 0.552 |
MOD_PKA_2 | 117 | 123 | PF00069 | 0.617 |
MOD_PKA_2 | 168 | 174 | PF00069 | 0.573 |
MOD_PKA_2 | 210 | 216 | PF00069 | 0.572 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.539 |
MOD_PKA_2 | 51 | 57 | PF00069 | 0.517 |
MOD_Plk_1 | 78 | 84 | PF00069 | 0.641 |
MOD_Plk_2-3 | 42 | 48 | PF00069 | 0.482 |
MOD_Plk_4 | 140 | 146 | PF00069 | 0.676 |
MOD_ProDKin_1 | 146 | 152 | PF00069 | 0.651 |
MOD_SUMO_for_1 | 43 | 46 | PF00179 | 0.576 |
MOD_SUMO_rev_2 | 38 | 45 | PF00179 | 0.655 |
MOD_SUMO_rev_2 | 46 | 53 | PF00179 | 0.606 |
MOD_SUMO_rev_2 | 79 | 89 | PF00179 | 0.464 |
TRG_DiLeu_BaEn_1 | 140 | 145 | PF01217 | 0.654 |
TRG_DiLeu_BaEn_1 | 73 | 78 | PF01217 | 0.547 |
TRG_ENDOCYTIC_2 | 160 | 163 | PF00928 | 0.679 |
TRG_ER_diArg_1 | 220 | 222 | PF00400 | 0.679 |
TRG_ER_diArg_1 | 30 | 32 | PF00400 | 0.514 |
TRG_ER_diArg_1 | 9 | 11 | PF00400 | 0.537 |
TRG_Pf-PMV_PEXEL_1 | 179 | 183 | PF00026 | 0.357 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3V3 | Leptomonas seymouri | 69% | 100% |
A0A0S4IMX4 | Bodo saltans | 36% | 100% |
A0A1X0NZD7 | Trypanosomatidae | 41% | 98% |
A0A3R7NXH1 | Trypanosoma rangeli | 42% | 98% |
A4HH15 | Leishmania braziliensis | 88% | 100% |
A4I444 | Leishmania infantum | 100% | 100% |
C9ZKR8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 98% |
E9ADK9 | Leishmania major | 95% | 100% |
E9AM72 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
O94651 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 26% | 97% |
V5BPW1 | Trypanosoma cruzi | 42% | 98% |